Multiple endocrine neoplasia type 2 other diagnostic studies
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 other diagnostic studies On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 other diagnostic studies |
FDA on Multiple endocrine neoplasia type 2 other diagnostic studies |
CDC on Multiple endocrine neoplasia type 2 other diagnostic studies |
Multiple endocrine neoplasia type 2 other diagnostic studies in the news |
Blogs on Multiple endocrine neoplasia type 2 other diagnostic studies |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Other diagnostic studies for multiple endocrine neoplasia type 2 include molecular genetic testing which include sequence analysis of select exons of mainly 10,11, 13-16 and sequence analysis of RET gene.
Other Diagnostic Studies
Molecular Genetic Testing
Test | Method |
---|---|
Select exon testing | Sequence analysis of select exons of mainly 10,11, 13-16 |
Single-gene testing | Sequence analysis of RET gene |
A multi-gene panel | RET and other genes of interest |
Histopathological Staining of the Biopsy
- Histopathological staining of medullary thyroid cancer
- (1)TTF1: negative in tumor cells
- (2)calcitonin: positive in tumor cells
- (3)chromogranin: positive in tumor cells
- (4)synaptophysin: positive in tumor cells.